Meso
Emerging
Active
Orexin receptor market interest
Score
0.4
Velocity
▲ 0.0
Articles
1
Sources
1
Summary
An article belongs to this narrative if it is about growing interest or investment in the orexin receptor agonist market.
Hypotheses
Pending
Due: June 1, 2026
ALKS stock volatility (30-day implied volatility) will increase by at least 25% within 60 days as market participants price in orexin receptor commercial opportunity potential
Pending
Due: July 31, 2026
Orexin receptor market expansion will result in ALKS achieving a market capitalization increase of at least 20% within 120 days, driven by investor sentiment and pipeline expansion expectations
Pending
Due: July 1, 2026
Increasing orexin receptor agonist market interest will drive ALKS stock price to outperform the broader biotech sector (XBI) by at least 15% within 90 days
Sources
Timeline
Last Updated
Apr 02, 2026